Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-14

Clinical Trial Update: Dose Escalation Trial of Traditional Chinese Medicine for Irritable Bowel Syndrome (TCM- IBS) [Phase 2]

View source ↗

Summary

Phase 2 dose-escalation trial of traditional Chinese medicine for irritable bowel syndrome has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED